Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 32.1 CNY -0.19% Market Closed
Market Cap: 24.7B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Other Liabilities
ÂĄ99.3m
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
3%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Liabilities
ÂĄ22m
CAGR 3-Years
-2%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Liabilities
ÂĄ94.5m
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
14%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Liabilities
ÂĄ42.6m
CAGR 3-Years
-29%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Liabilities
ÂĄ892.5m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
17%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Liabilities
ÂĄ26.8m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Glance View

Market Cap
24.7B CNY
Industry
Pharmaceuticals

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. engages in the research, development, processing, wholesale, retail, and manufacturing of Chinese herbal medicines, Chinese patent medicines, Chinese medicine decoction tablets, western medicine preparations, and other medical and health products. The company is headquartered in Tianjin, Tianjin and currently employs 4,650 full-time employees. The company went IPO on 2001-06-06. The firm's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The firm's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Intrinsic Value
42.52 CNY
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Other Liabilities?
Other Liabilities
99.3m CNY

Based on the financial report for Jun 30, 2024, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Other Liabilities amounts to 99.3m CNY.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
3%

Over the last year, the Other Liabilities growth was -11%. The average annual Other Liabilities growth rates for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd have been -9% over the past three years , -5% over the past five years , and 3% over the past ten years .

Back to Top